Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

People who inject drugs news


From To
The Crucial Link Between Drug Policy and HIV Rates

The evidence that a government’s posture toward drug use affects HIV rates is compelling, and there are a number of case studies from around the world that suggest a therapy-first approach could significantly lower HIV transmission rates among PWID.

18 September 2018
MD Magazine
New study finds HIV outbreak in Indiana could have been prevented

An HIV outbreak among people who inject drugs in Indiana from 2011 to 2015 could have been avoided if the state’s top health and elected officials had acted sooner on warnings, a new study by the Yale School of Public Health finds.

14 September 2018
Yale News
Indonesia: tackling HIV in one of the world’s fastest-growing epidemics

A prospective study that recruited a significant proportion of people newly diagnosed with HIV in four locations in Indonesia and offered them immediate antiretroviral therapy (ART)

04 September 2018
Gus Cairns
New program boosts use of HIV medications in injection-drug users

A relatively simple effort to provide counseling and connect injection-drug users with resources could prove powerful against the spread of HIV in a notoriously hard-to-reach population, new research suggests.

31 August 2018
Eurekalert Inf Dis
The CDC Predicted An Opioid-Driven HIV Outbreak. Now It's Found One In Massachusetts.

An HIV outbreak in Massachusetts has grown to 129 confirmed cases, state officials said, an alarming cluster largely driven by drug users sharing needles.

28 August 2018
BuzzFeed News
UK study finds buprenorphine’s lifesaving lead over methadone has been undermined by poorer retention

This study compared two types of opioid substitution treatment, testing the theory that buprenorphine is associated with a lower risk of mortality than methadone. An analysis of patient care records found that during treatment at UK primary care practices, buprenorphine was consistently associated with lower rates of overall mortality and drug-related poisoning deaths than methadone. However, across the population buprenorphine is unlikely to give greater overall protection because of the relatively short duration of treatment.

24 August 2018
Drug & Alcohol Findings
People with HIV receiving methadone and HIV drugs spend less time with detectable viral load

People on methadone maintenance treatment spent less time with a detectable viral load above 1500 copies/ml, potentially reducing the risk of HIV transmission, a study presented at

10 August 2018
Keith Alcorn
Access to opioid agonist therapy in Russia: time for reform (free registration required)

The efforts to halt the spread of HIV in Russia are hindered by the policies of its government, which has scaled back harm reduction efforts and denied access to opioid agonist treatment to 1·8 million people who inject drugs in Russia, many of whom inject opioids.

07 August 2018
The Lancet
Harm Reduction International appoints Naomi Burke-Shyne as executive director

Harm Reduction International (HRI) announced today the appointment of Naomi Burke-Shyne as its new executive director. She will take the position on 1 September 2018, replacing Dr Rick Lines who has served as executive director since 2010.

31 July 2018
Harm Reduction International
How lessons from HIV/AIDS crisis can apply to the opioid crisis

As someone who participated in AIDS activism in the early 1990s, and now works on ending the overdose deaths, the lens through which I view these parallels begins with this insight: Every public health crisis must be understood as both a medical issue and a social issue. Health care is necessary but not sufficient to reverse the course of an epidemic. We must also fight to remove barriers to access, and tackle the policies that have put so many people in harm’s way.

30 July 2018

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.